Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $2.5 million.

  • Agilon Health's Gains from Investment Securities rose 81213.87% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 3865.74%. This contributed to the annual value of -$887000.0 for FY2024, which is 12193.37% down from last year.
  • According to the latest figures from Q3 2025, Agilon Health's Gains from Investment Securities is $2.5 million, which was up 81213.87% from $878000.0 recorded in Q2 2025.
  • In the past 5 years, Agilon Health's Gains from Investment Securities ranged from a high of $2.5 million in Q4 2023 and a low of -$1.8 million during Q1 2021
  • In the last 5 years, Agilon Health's Gains from Investment Securities had a median value of $472000.0 in 2024 and averaged $482159.4.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first tumbled by 20318.07% in 2023, then soared by 168561428.57% in 2024.
  • Agilon Health's Gains from Investment Securities (Quarter) stood at $53000.0 in 2021, then surged by 2330.19% to $1.3 million in 2022, then skyrocketed by 96.66% to $2.5 million in 2023, then tumbled by 154.4% to -$1.4 million in 2024, then skyrocketed by 278.81% to $2.5 million in 2025.
  • Its Gains from Investment Securities stands at $2.5 million for Q3 2025, versus $878000.0 for Q2 2025 and $2.2 million for Q1 2025.